chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Cough, Eye pruritus, Lethargy, Oropharyngeal pain
Clinical narrative: Fever, aches and pains - 12 hours   still continuing to have  lethargy ,cough, sore throat, runny nose, burning, itchy eyes
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rhinorrhoea
Clinical narrative: Fever, aches and pains - 12 hours   still continuing to have  lethargy ,cough, sore throat, runny nose, burning, itchy eyes
Age: 70.0
Sex: F
Vaccine: RSV
Symptoms: Contusion, Immune thrombocytopenia, Platelet count decreased
Clinical narrative: Patient developed low platelet count following vaccine administration - patient had blood work done was asymptomatic at time but ultimately developed ITP and had bruising to extremities. Patient also received FluZone on 11/18/24.
Age: 70.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: Current guidelines recommend 1 dose of the rsv. she was given a second dose
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia universalis
Clinical narrative: First two vaccines, Pfizer. Third vaccine Moderna. Initially developed Alopecia Ariata. Now has expanded to Alopecia Universalis.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, Blood loss anaemia, COVID-19, Chronic kidney disease
Clinical narrative: Name: Medical Record #:   Age:  73 y.o. DOB:  Admit date: 1/1/2025  Discharge date: 1/3/2025  Admitting Physician: DO  Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP, Reason for Admission: melenic stool, shortness of breath, fatigue  Brief Summary of Hospital Stay:  Patient is a 73 y.o. w/ pmhx CAD s/p CABG x4, HTN, HLD, chronic HFpEF, paroxysmal afib that presents to the hospital with complaints of shortness of breath, cough, increased fatigue, and dark stools. Anticoagulation was held and patient was seen by GI during admission and melenic stool believed to be from significant epistaxis patient had a week ago. Hemoglobin was trended; remained stable and melenic stools resolved. Patient was also + for COVID-19 and in hypoxic respiratory failure. Was treated with supportive care and ultimately weaned off oxygen. Patient doing well now and hemodynamically stable for discharge. Will need PCP follow up for Transition of Care, follow up at Warfarin clinic, repeat BMP in 1 week, and repeat PT/INR on 1/6/25. Will increase torsemide on discharge to increase diuresis due to significant edema in bilateral lower extremities.  Hospital Course:  Melenic stool, Concern for UGIB (resolved) Acute blood loss anemia (resolved) - melenic stool likely 2/2 epistaxis from 12/27/24 , no plans for EGD  - protonix, general diet - avoid NSAIDs - Hgb goal >7, tranfuse if under. Trend cbc - GI consulted, appreciate recs  Acute hypoxic respiratory failure (resolved) 2/2 +COVID-19 on RVP  Wheezing, cough (resolved) - 1/1/25 RVP - +COVID-19 - symptomatic care, albuterol, tessalon, IS, flutter valve, mucinex  Chronic HFpEF - NYHA class II - LHC 4/2024 - 3-vessel-disease, significant stenosis in 2nd diagonal branch, lad, large ramus intermedius branch, left circumflex coronary artery and RCA. LVEF 60% - lasix - strict I/Os, daily weights  Paroxysmal afib - chadsvasc 5, warfarin held, resume on dc  CAD s/p CABGx4 7/2024 - asa, statin T2DM - A1c 5.9. Lispro, lantus HTN - carvedilol, imdur, amlodipine CKD3a - stable, baseline Cr 1.6 HLD - atorvastatin Chronic LE wounds - WOCN  Issues Requiring Follow Up: PCP - transition of care Warfarin Clinic - PT/INR Discharged to Home Health Care.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery stenosis, Cough, Dyspnoea, Ejection fraction normal, Epistaxis
Clinical narrative: Name: Medical Record #:   Age:  73 y.o. DOB:  Admit date: 1/1/2025  Discharge date: 1/3/2025  Admitting Physician: DO  Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP, Reason for Admission: melenic stool, shortness of breath, fatigue  Brief Summary of Hospital Stay:  Patient is a 73 y.o. w/ pmhx CAD s/p CABG x4, HTN, HLD, chronic HFpEF, paroxysmal afib that presents to the hospital with complaints of shortness of breath, cough, increased fatigue, and dark stools. Anticoagulation was held and patient was seen by GI during admission and melenic stool believed to be from significant epistaxis patient had a week ago. Hemoglobin was trended; remained stable and melenic stools resolved. Patient was also + for COVID-19 and in hypoxic respiratory failure. Was treated with supportive care and ultimately weaned off oxygen. Patient doing well now and hemodynamically stable for discharge. Will need PCP follow up for Transition of Care, follow up at Warfarin clinic, repeat BMP in 1 week, and repeat PT/INR on 1/6/25. Will increase torsemide on discharge to increase diuresis due to significant edema in bilateral lower extremities.  Hospital Course:  Melenic stool, Concern for UGIB (resolved) Acute blood loss anemia (resolved) - melenic stool likely 2/2 epistaxis from 12/27/24 , no plans for EGD  - protonix, general diet - avoid NSAIDs - Hgb goal >7, tranfuse if under. Trend cbc - GI consulted, appreciate recs  Acute hypoxic respiratory failure (resolved) 2/2 +COVID-19 on RVP  Wheezing, cough (resolved) - 1/1/25 RVP - +COVID-19 - symptomatic care, albuterol, tessalon, IS, flutter valve, mucinex  Chronic HFpEF - NYHA class II - LHC 4/2024 - 3-vessel-disease, significant stenosis in 2nd diagonal branch, lad, large ramus intermedius branch, left circumflex coronary artery and RCA. LVEF 60% - lasix - strict I/Os, daily weights  Paroxysmal afib - chadsvasc 5, warfarin held, resume on dc  CAD s/p CABGx4 7/2024 - asa, statin T2DM - A1c 5.9. Lispro, lantus HTN - carvedilol, imdur, amlodipine CKD3a - stable, baseline Cr 1.6 HLD - atorvastatin Chronic LE wounds - WOCN  Issues Requiring Follow Up: PCP - transition of care Warfarin Clinic - PT/INR Discharged to Home Health Care.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Faeces discoloured, Fatigue, Full blood count, Glycosylated haemoglobin normal, Haemoglobin
Clinical narrative: Name: Medical Record #:   Age:  73 y.o. DOB:  Admit date: 1/1/2025  Discharge date: 1/3/2025  Admitting Physician: DO  Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP, Reason for Admission: melenic stool, shortness of breath, fatigue  Brief Summary of Hospital Stay:  Patient is a 73 y.o. w/ pmhx CAD s/p CABG x4, HTN, HLD, chronic HFpEF, paroxysmal afib that presents to the hospital with complaints of shortness of breath, cough, increased fatigue, and dark stools. Anticoagulation was held and patient was seen by GI during admission and melenic stool believed to be from significant epistaxis patient had a week ago. Hemoglobin was trended; remained stable and melenic stools resolved. Patient was also + for COVID-19 and in hypoxic respiratory failure. Was treated with supportive care and ultimately weaned off oxygen. Patient doing well now and hemodynamically stable for discharge. Will need PCP follow up for Transition of Care, follow up at Warfarin clinic, repeat BMP in 1 week, and repeat PT/INR on 1/6/25. Will increase torsemide on discharge to increase diuresis due to significant edema in bilateral lower extremities.  Hospital Course:  Melenic stool, Concern for UGIB (resolved) Acute blood loss anemia (resolved) - melenic stool likely 2/2 epistaxis from 12/27/24 , no plans for EGD  - protonix, general diet - avoid NSAIDs - Hgb goal >7, tranfuse if under. Trend cbc - GI consulted, appreciate recs  Acute hypoxic respiratory failure (resolved) 2/2 +COVID-19 on RVP  Wheezing, cough (resolved) - 1/1/25 RVP - +COVID-19 - symptomatic care, albuterol, tessalon, IS, flutter valve, mucinex  Chronic HFpEF - NYHA class II - LHC 4/2024 - 3-vessel-disease, significant stenosis in 2nd diagonal branch, lad, large ramus intermedius branch, left circumflex coronary artery and RCA. LVEF 60% - lasix - strict I/Os, daily weights  Paroxysmal afib - chadsvasc 5, warfarin held, resume on dc  CAD s/p CABGx4 7/2024 - asa, statin T2DM - A1c 5.9. Lispro, lantus HTN - carvedilol, imdur, amlodipine CKD3a - stable, baseline Cr 1.6 HLD - atorvastatin Chronic LE wounds - WOCN  Issues Requiring Follow Up: PCP - transition of care Warfarin Clinic - PT/INR Discharged to Home Health Care.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Heart failure with preserved ejection fraction, Limb injury, Melaena, Oedema peripheral, Respiratory viral panel
Clinical narrative: Name: Medical Record #:   Age:  73 y.o. DOB:  Admit date: 1/1/2025  Discharge date: 1/3/2025  Admitting Physician: DO  Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP, Reason for Admission: melenic stool, shortness of breath, fatigue  Brief Summary of Hospital Stay:  Patient is a 73 y.o. w/ pmhx CAD s/p CABG x4, HTN, HLD, chronic HFpEF, paroxysmal afib that presents to the hospital with complaints of shortness of breath, cough, increased fatigue, and dark stools. Anticoagulation was held and patient was seen by GI during admission and melenic stool believed to be from significant epistaxis patient had a week ago. Hemoglobin was trended; remained stable and melenic stools resolved. Patient was also + for COVID-19 and in hypoxic respiratory failure. Was treated with supportive care and ultimately weaned off oxygen. Patient doing well now and hemodynamically stable for discharge. Will need PCP follow up for Transition of Care, follow up at Warfarin clinic, repeat BMP in 1 week, and repeat PT/INR on 1/6/25. Will increase torsemide on discharge to increase diuresis due to significant edema in bilateral lower extremities.  Hospital Course:  Melenic stool, Concern for UGIB (resolved) Acute blood loss anemia (resolved) - melenic stool likely 2/2 epistaxis from 12/27/24 , no plans for EGD  - protonix, general diet - avoid NSAIDs - Hgb goal >7, tranfuse if under. Trend cbc - GI consulted, appreciate recs  Acute hypoxic respiratory failure (resolved) 2/2 +COVID-19 on RVP  Wheezing, cough (resolved) - 1/1/25 RVP - +COVID-19 - symptomatic care, albuterol, tessalon, IS, flutter valve, mucinex  Chronic HFpEF - NYHA class II - LHC 4/2024 - 3-vessel-disease, significant stenosis in 2nd diagonal branch, lad, large ramus intermedius branch, left circumflex coronary artery and RCA. LVEF 60% - lasix - strict I/Os, daily weights  Paroxysmal afib - chadsvasc 5, warfarin held, resume on dc  CAD s/p CABGx4 7/2024 - asa, statin T2DM - A1c 5.9. Lispro, lantus HTN - carvedilol, imdur, amlodipine CKD3a - stable, baseline Cr 1.6 HLD - atorvastatin Chronic LE wounds - WOCN  Issues Requiring Follow Up: PCP - transition of care Warfarin Clinic - PT/INR Discharged to Home Health Care.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Type 2 diabetes mellitus, Wheezing
Clinical narrative: Name: Medical Record #:   Age:  73 y.o. DOB:  Admit date: 1/1/2025  Discharge date: 1/3/2025  Admitting Physician: DO  Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP, Reason for Admission: melenic stool, shortness of breath, fatigue  Brief Summary of Hospital Stay:  Patient is a 73 y.o. w/ pmhx CAD s/p CABG x4, HTN, HLD, chronic HFpEF, paroxysmal afib that presents to the hospital with complaints of shortness of breath, cough, increased fatigue, and dark stools. Anticoagulation was held and patient was seen by GI during admission and melenic stool believed to be from significant epistaxis patient had a week ago. Hemoglobin was trended; remained stable and melenic stools resolved. Patient was also + for COVID-19 and in hypoxic respiratory failure. Was treated with supportive care and ultimately weaned off oxygen. Patient doing well now and hemodynamically stable for discharge. Will need PCP follow up for Transition of Care, follow up at Warfarin clinic, repeat BMP in 1 week, and repeat PT/INR on 1/6/25. Will increase torsemide on discharge to increase diuresis due to significant edema in bilateral lower extremities.  Hospital Course:  Melenic stool, Concern for UGIB (resolved) Acute blood loss anemia (resolved) - melenic stool likely 2/2 epistaxis from 12/27/24 , no plans for EGD  - protonix, general diet - avoid NSAIDs - Hgb goal >7, tranfuse if under. Trend cbc - GI consulted, appreciate recs  Acute hypoxic respiratory failure (resolved) 2/2 +COVID-19 on RVP  Wheezing, cough (resolved) - 1/1/25 RVP - +COVID-19 - symptomatic care, albuterol, tessalon, IS, flutter valve, mucinex  Chronic HFpEF - NYHA class II - LHC 4/2024 - 3-vessel-disease, significant stenosis in 2nd diagonal branch, lad, large ramus intermedius branch, left circumflex coronary artery and RCA. LVEF 60% - lasix - strict I/Os, daily weights  Paroxysmal afib - chadsvasc 5, warfarin held, resume on dc  CAD s/p CABGx4 7/2024 - asa, statin T2DM - A1c 5.9. Lispro, lantus HTN - carvedilol, imdur, amlodipine CKD3a - stable, baseline Cr 1.6 HLD - atorvastatin Chronic LE wounds - WOCN  Issues Requiring Follow Up: PCP - transition of care Warfarin Clinic - PT/INR Discharged to Home Health Care.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest X-ray, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/2/2025 Discharge Date: Jan 3, 2025 Discharge Disposition:  home or self care   Active Issues Requiring Follow-up: COVID-19, COPD DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation (HCC) [J44.1]  HOSPITAL COURSE: 88 y.o. male with a history of chronic obstructive pulmonary disease, anxiety, and hypertension who presented for shortness of breath and hypoxia.  Patient has chronic obstructive pulmonary disease and uses 2 L supplemental oxygen at night.  SOB - resolved Acute on chronic hypoxic respiratory failure - resolved 2/2 COPD Exacerbation - resolved 2/2 COVID-19 - On Chronic 2L of O2 at night home. Had walk test prior to discharge. Patient did not require supplemental O2. Discussed case with patient and family who is bedside. Patient requesting discharge. Family believe that he has improved significantly since admission are comfortable taking him home.  - CXR - Continue home inhalers  - O2 supplementation PRN - DuoNebs PRN  - IV Methylprednisolone during hospitalization. Prednisone 50 mg daily at discharge  - Mucinex 1200 mg BID - Echocardiogram results pending at time of discharge - Has Pulm follow up at the end of January  Discharged to Home
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Respiratory failure
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/2/2025 Discharge Date: Jan 3, 2025 Discharge Disposition:  home or self care   Active Issues Requiring Follow-up: COVID-19, COPD DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation (HCC) [J44.1]  HOSPITAL COURSE: 88 y.o. male with a history of chronic obstructive pulmonary disease, anxiety, and hypertension who presented for shortness of breath and hypoxia.  Patient has chronic obstructive pulmonary disease and uses 2 L supplemental oxygen at night.  SOB - resolved Acute on chronic hypoxic respiratory failure - resolved 2/2 COPD Exacerbation - resolved 2/2 COVID-19 - On Chronic 2L of O2 at night home. Had walk test prior to discharge. Patient did not require supplemental O2. Discussed case with patient and family who is bedside. Patient requesting discharge. Family believe that he has improved significantly since admission are comfortable taking him home.  - CXR - Continue home inhalers  - O2 supplementation PRN - DuoNebs PRN  - IV Methylprednisolone during hospitalization. Prednisone 50 mg daily at discharge  - Mucinex 1200 mg BID - Echocardiogram results pending at time of discharge - Has Pulm follow up at the end of January  Discharged to Home
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood creatinine increased, COVID-19, Chest X-ray normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/2/2025 Discharge Date: Jan 4, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1]  HOSPITAL COURSE: Patient was an 83-year-old male history of diabetes, hypertension hyperlipidemia presents for chief complaint of confusion weakness fever and cough at home.  He was found to be COVID-19 positive.  He was satting well on room air.  X-ray without obvious infiltrates.  Labs were notable for elevated creatinine with high anion gap metabolic acidosis with lactic acidosis.  Lactic acidosis likely largely secondary to acute kidney injury and home metformin use resolved following holding metformin IV fluids and serial monitoring.  Creatinine downtrending likely indicating some level of CKD superimposed on acute kidney injury.  Patient was A1c is well-controlled without hyperglycemia during his stay.  We will discontinue his metformin due to likely worsening underlying renal disease as well as patient was seems well controlled at this time.  He was encouraged to discuss with his primary care provider alternative therapy versus decreased dosing.  He was evaluated by PT OT services deemed appropriate for home care.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Confusional state, Cough, Glycosylated haemoglobin normal, Lactic acidosis
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/2/2025 Discharge Date: Jan 4, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1]  HOSPITAL COURSE: Patient was an 83-year-old male history of diabetes, hypertension hyperlipidemia presents for chief complaint of confusion weakness fever and cough at home.  He was found to be COVID-19 positive.  He was satting well on room air.  X-ray without obvious infiltrates.  Labs were notable for elevated creatinine with high anion gap metabolic acidosis with lactic acidosis.  Lactic acidosis likely largely secondary to acute kidney injury and home metformin use resolved following holding metformin IV fluids and serial monitoring.  Creatinine downtrending likely indicating some level of CKD superimposed on acute kidney injury.  Patient was A1c is well-controlled without hyperglycemia during his stay.  We will discontinue his metformin due to likely worsening underlying renal disease as well as patient was seems well controlled at this time.  He was encouraged to discuss with his primary care provider alternative therapy versus decreased dosing.  He was evaluated by PT OT services deemed appropriate for home care.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic acidosis, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/2/2025 Discharge Date: Jan 4, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1]  HOSPITAL COURSE: Patient was an 83-year-old male history of diabetes, hypertension hyperlipidemia presents for chief complaint of confusion weakness fever and cough at home.  He was found to be COVID-19 positive.  He was satting well on room air.  X-ray without obvious infiltrates.  Labs were notable for elevated creatinine with high anion gap metabolic acidosis with lactic acidosis.  Lactic acidosis likely largely secondary to acute kidney injury and home metformin use resolved following holding metformin IV fluids and serial monitoring.  Creatinine downtrending likely indicating some level of CKD superimposed on acute kidney injury.  Patient was A1c is well-controlled without hyperglycemia during his stay.  We will discontinue his metformin due to likely worsening underlying renal disease as well as patient was seems well controlled at this time.  He was encouraged to discuss with his primary care provider alternative therapy versus decreased dosing.  He was evaluated by PT OT services deemed appropriate for home care.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cardiac failure congestive, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Name:   Medical Record #:   Age:  89 y.o. DOB:   Admit date: 1/2/2025  Discharge date: 1/4/2025  Admitting Physician: MD  Attending Physician at the Time of Discharge:  DO  Primary Care Physician: MD,   Reason for Admission: COPD exacerbation due to COVID  Brief Summary of Hospital Stay:   Patient is a 89 y.o. year old female with past medical history of HFpEF, permanent atrial fibrillation with pacemaker, COPD, hypothyroidism, hypertension, hyperlipidemia, presenting to Hospital with one-week history of cough, generalized weakness, loss of appetite, nausea/vomiting.  She was found to be COVID positive with concerns for chronic obstructive pulmonary disease exacerbation as well as CHF exacerbation.  She was given 40 mg of prednisone daily and DuoNebs p.r.n. as well as supportive treatment and lasix for diuresis. She improved significantly over the next 2 days and was deemed stable for discharge back home 1/4/2025.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Name:   Medical Record #:   Age:  89 y.o. DOB:   Admit date: 1/2/2025  Discharge date: 1/4/2025  Admitting Physician: MD  Attending Physician at the Time of Discharge:  DO  Primary Care Physician: MD,   Reason for Admission: COPD exacerbation due to COVID  Brief Summary of Hospital Stay:   Patient is a 89 y.o. year old female with past medical history of HFpEF, permanent atrial fibrillation with pacemaker, COPD, hypothyroidism, hypertension, hyperlipidemia, presenting to Hospital with one-week history of cough, generalized weakness, loss of appetite, nausea/vomiting.  She was found to be COVID positive with concerns for chronic obstructive pulmonary disease exacerbation as well as CHF exacerbation.  She was given 40 mg of prednisone daily and DuoNebs p.r.n. as well as supportive treatment and lasix for diuresis. She improved significantly over the next 2 days and was deemed stable for discharge back home 1/4/2025.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Chills, Herpes zoster, Influenza like illness, Rash
Clinical narrative: Received the Shingrix vaccine dose #1 on a Monday morning, 12/30/24 at 9:00am and on following Thursday, 1/2/25 at 5:00pm, fell ill with the Shingles. Rash started on left upper chest and  progressed to left shoulder and left back.  Rash accompanied by chills and other flu-like symptoms. Shingles diagnosis made on Saturday, 1/4/25, via visual exam by physician and subsequently tested positive on 1/7/25 via PCR. As of this VAERS submission date (1/9/25), significant pain from rash/blisters persists.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Varicella virus test positive
Clinical narrative: Received the Shingrix vaccine dose #1 on a Monday morning, 12/30/24 at 9:00am and on following Thursday, 1/2/25 at 5:00pm, fell ill with the Shingles. Rash started on left upper chest and  progressed to left shoulder and left back.  Rash accompanied by chills and other flu-like symptoms. Shingles diagnosis made on Saturday, 1/4/25, via visual exam by physician and subsequently tested positive on 1/7/25 via PCR. As of this VAERS submission date (1/9/25), significant pain from rash/blisters persists.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Hypoxia, Laboratory test
Clinical narrative: Physician Discharge Summary Hospital Name:   Medical Record #: Age:  94 y.o.  DOB:  Admit date: 1/2/2025   Discharge date: 1/5/2025  Attending Physician at the Time of Discharge: MD  Reason for Admission: per H&P Patient 94 M who has been a resident at the Facility the past 2 years. He resides in the independent living portion. He does not use supplemental home O2. Ambulates with cane and walker assist at times. Non smoker. Takes a 1/2 glass of wine daily.  Acute onset feeling unwell when he awoke yesterday. Felt feverish, globally weak, achy all over. + sore throat and clear nasal discharge. No known sick contacts recently. Symptoms did not improve, and so he was brought to the ED.  ED eval shows basically stable routine labwork. COVID-19 PCR was positive. CXR did not show frank lung infiltrates. He was observed hypoxic needing O2 support by nasal canula. Brief Summary of Hospital Stay:   Patient was admitted to medicine.  He was started on dexamethasone. He was weaned off O2. PT/OT were consulted - no further skilled therapy recommended. He was given symptomatic treatment with ipratropium nasal spray and throat lozenges. His avapro was held - will re-start at a lower dose until seen by his PCP.. Discharged to Home.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: Physician Discharge Summary Hospital Name:   Medical Record #: Age:  94 y.o.  DOB:  Admit date: 1/2/2025   Discharge date: 1/5/2025  Attending Physician at the Time of Discharge: MD  Reason for Admission: per H&P Patient 94 M who has been a resident at the Facility the past 2 years. He resides in the independent living portion. He does not use supplemental home O2. Ambulates with cane and walker assist at times. Non smoker. Takes a 1/2 glass of wine daily.  Acute onset feeling unwell when he awoke yesterday. Felt feverish, globally weak, achy all over. + sore throat and clear nasal discharge. No known sick contacts recently. Symptoms did not improve, and so he was brought to the ED.  ED eval shows basically stable routine labwork. COVID-19 PCR was positive. CXR did not show frank lung infiltrates. He was observed hypoxic needing O2 support by nasal canula. Brief Summary of Hospital Stay:   Patient was admitted to medicine.  He was started on dexamethasone. He was weaned off O2. PT/OT were consulted - no further skilled therapy recommended. He was given symptomatic treatment with ipratropium nasal spray and throat lozenges. His avapro was held - will re-start at a lower dose until seen by his PCP.. Discharged to Home.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Physician Discharge Summary Hospital Name:   Medical Record #: Age:  94 y.o.  DOB:  Admit date: 1/2/2025   Discharge date: 1/5/2025  Attending Physician at the Time of Discharge: MD  Reason for Admission: per H&P Patient 94 M who has been a resident at the Facility the past 2 years. He resides in the independent living portion. He does not use supplemental home O2. Ambulates with cane and walker assist at times. Non smoker. Takes a 1/2 glass of wine daily.  Acute onset feeling unwell when he awoke yesterday. Felt feverish, globally weak, achy all over. + sore throat and clear nasal discharge. No known sick contacts recently. Symptoms did not improve, and so he was brought to the ED.  ED eval shows basically stable routine labwork. COVID-19 PCR was positive. CXR did not show frank lung infiltrates. He was observed hypoxic needing O2 support by nasal canula. Brief Summary of Hospital Stay:   Patient was admitted to medicine.  He was started on dexamethasone. He was weaned off O2. PT/OT were consulted - no further skilled therapy recommended. He was given symptomatic treatment with ipratropium nasal spray and throat lozenges. His avapro was held - will re-start at a lower dose until seen by his PCP.. Discharged to Home.
Age: 72.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: It was not an adverse event; this is to report patient received duplicate RSV vaccine
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Name:   Medical Record #:  Age:  75 y.o. DOB:   Admit date: 1/3/2025  Discharge date: 1/6/2025  Admitting Physician:  DO  Attending Physician at the Time of Discharge:  DO  Primary Care Physician: MD  Reason for Admission:  COPD exacerbation 2/2 to COVID-19  Brief Summary of Hospital Stay:  Patient is a 75 y.o. year old male with COPD (not on home oxygen), OSA on CPAP nightly, diabetes mellitus type 2, hypertension, hyperlipidemia, and obesity who presented to the ED on 1/3/2025 with cough, shortness of breath.  He was found to be positive for COVID-19.  Due to hypoxia, he met criteria for COVID treatment.  He was given 5 days of remdesivir as well as Decadron.  He was also treated with scheduled Symbicort and Spiriva, p.r.n. DuoNebs.  He did improve, with decreasing oxygen requirements over the last couple of days.  His course was complicated by high hyperglycemia due to the steroids that he had been receiving.  This was managed with insulin.  He was maintaining saturations off oxygen, deemed stable for discharge to home 1/6/2025.  He was not prescribed steroids at discharge due to improvement in symptoms as well as risk of hyperglycemia. Discharged to Home Health Care
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, SARS-CoV-2 test
Clinical narrative: Name:   Medical Record #:  Age:  75 y.o. DOB:   Admit date: 1/3/2025  Discharge date: 1/6/2025  Admitting Physician:  DO  Attending Physician at the Time of Discharge:  DO  Primary Care Physician: MD  Reason for Admission:  COPD exacerbation 2/2 to COVID-19  Brief Summary of Hospital Stay:  Patient is a 75 y.o. year old male with COPD (not on home oxygen), OSA on CPAP nightly, diabetes mellitus type 2, hypertension, hyperlipidemia, and obesity who presented to the ED on 1/3/2025 with cough, shortness of breath.  He was found to be positive for COVID-19.  Due to hypoxia, he met criteria for COVID treatment.  He was given 5 days of remdesivir as well as Decadron.  He was also treated with scheduled Symbicort and Spiriva, p.r.n. DuoNebs.  He did improve, with decreasing oxygen requirements over the last couple of days.  His course was complicated by high hyperglycemia due to the steroids that he had been receiving.  This was managed with insulin.  He was maintaining saturations off oxygen, deemed stable for discharge to home 1/6/2025.  He was not prescribed steroids at discharge due to improvement in symptoms as well as risk of hyperglycemia. Discharged to Home Health Care
Age: 28.0
Sex: F
Vaccine: COVID19, FLU3, PNC20
Symptoms: Injection site erythema, Injection site pruritus, Limb mass
Clinical narrative: I recieved a shot on my left arm for flu and covid (moderna) and the day after I saw I had developed a lump over my shoulder (not where the shot was given) and the place where I hot the shot also has been very red and itchy.
Age: 67.0
Sex: F
Vaccine: PNC21
Symptoms: Rash
Clinical narrative: large wheel rash larger than a grapefruit in size  with streaking down to inside of arm indicative of cellulitis. referred patient to dr.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood creatinine increased, Blood loss anaemia, Blood potassium increased
Clinical narrative: HOSPITALS CRITICAL CARE Discharged as Deceased Summary  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO  Admission Date: 12/31/2024 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hemorrhagic shock [R57.8] Hypotension [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID [U07.1]  HOSPITAL COURSE: Patient is a 72 y.o. female w/ PMHx metastatic squamous cell carcinoma of the right upper lobe with T12 pathologic fracture status post kyphoplasty, atrial fibrillation, HFrEF (LVEF 40%) and chronic lower back pain who presented from local skilled nursing home 12/31/2024 9:08 PM due to nausea, vomiting, and generalized weakness found to be in shock. ICU consulted for medical admission. Workup in the ED showed COVID-19 infection, normocytic anemia, hemoglobin 6.3 down from 11.6 (12/7/24), acute kidney injury creatinine 2.4 up from 0.9, hyperkalemia (K 6.1), WBCs 20.4. CT abdomen and pelvis with new L1 end-plate and left iliac lytic lesions along with left oblique musculature soft tissue metastasis. CT angiogram with increasing size of the right lower lobe nodule since (10/24/24). The patient remained hypotensive despite 2 L normal saline, and 1 unit packed red blood cells.  Peripheral norepinephrine was started in the emergency department in the patient was transferred to the ICU for further management.  Patient was empirically treated with antibiotics, vasopressors were weaned off.  The patient did have melanotic stools (1/3/25, consistent with GI bleeding as the source of her acute blood loss anemia.  Gastroenterology was consulted.  Radiation oncology was also consulted.  Patient's condition medically improved (1/4/25) and she was transferred to the Internal Medicine Service.  A rapid response was initiated (1/5/25) due to hypoxia and hypotension.  After discussing the patient's poor prognosis with family goals of care were transition to comfort care.  The patient developed asystole (lead placement confirmed), pupils unresponsive, no carotid pulse palpated, and she was pronounced dead at 01:50 (1/6/25).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Bone lesion, COVID-19, Cardiac arrest, Computerised tomogram abdomen abnormal, Computerised tomogram thorax
Clinical narrative: HOSPITALS CRITICAL CARE Discharged as Deceased Summary  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO  Admission Date: 12/31/2024 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hemorrhagic shock [R57.8] Hypotension [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID [U07.1]  HOSPITAL COURSE: Patient is a 72 y.o. female w/ PMHx metastatic squamous cell carcinoma of the right upper lobe with T12 pathologic fracture status post kyphoplasty, atrial fibrillation, HFrEF (LVEF 40%) and chronic lower back pain who presented from local skilled nursing home 12/31/2024 9:08 PM due to nausea, vomiting, and generalized weakness found to be in shock. ICU consulted for medical admission. Workup in the ED showed COVID-19 infection, normocytic anemia, hemoglobin 6.3 down from 11.6 (12/7/24), acute kidney injury creatinine 2.4 up from 0.9, hyperkalemia (K 6.1), WBCs 20.4. CT abdomen and pelvis with new L1 end-plate and left iliac lytic lesions along with left oblique musculature soft tissue metastasis. CT angiogram with increasing size of the right lower lobe nodule since (10/24/24). The patient remained hypotensive despite 2 L normal saline, and 1 unit packed red blood cells.  Peripheral norepinephrine was started in the emergency department in the patient was transferred to the ICU for further management.  Patient was empirically treated with antibiotics, vasopressors were weaned off.  The patient did have melanotic stools (1/3/25, consistent with GI bleeding as the source of her acute blood loss anemia.  Gastroenterology was consulted.  Radiation oncology was also consulted.  Patient's condition medically improved (1/4/25) and she was transferred to the Internal Medicine Service.  A rapid response was initiated (1/5/25) due to hypoxia and hypotension.  After discussing the patient's poor prognosis with family goals of care were transition to comfort care.  The patient developed asystole (lead placement confirmed), pupils unresponsive, no carotid pulse palpated, and she was pronounced dead at 01:50 (1/6/25).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Gastrointestinal haemorrhage, Haemoglobin decreased, Hyperkalaemia, Hypotension
Clinical narrative: HOSPITALS CRITICAL CARE Discharged as Deceased Summary  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO  Admission Date: 12/31/2024 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hemorrhagic shock [R57.8] Hypotension [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID [U07.1]  HOSPITAL COURSE: Patient is a 72 y.o. female w/ PMHx metastatic squamous cell carcinoma of the right upper lobe with T12 pathologic fracture status post kyphoplasty, atrial fibrillation, HFrEF (LVEF 40%) and chronic lower back pain who presented from local skilled nursing home 12/31/2024 9:08 PM due to nausea, vomiting, and generalized weakness found to be in shock. ICU consulted for medical admission. Workup in the ED showed COVID-19 infection, normocytic anemia, hemoglobin 6.3 down from 11.6 (12/7/24), acute kidney injury creatinine 2.4 up from 0.9, hyperkalemia (K 6.1), WBCs 20.4. CT abdomen and pelvis with new L1 end-plate and left iliac lytic lesions along with left oblique musculature soft tissue metastasis. CT angiogram with increasing size of the right lower lobe nodule since (10/24/24). The patient remained hypotensive despite 2 L normal saline, and 1 unit packed red blood cells.  Peripheral norepinephrine was started in the emergency department in the patient was transferred to the ICU for further management.  Patient was empirically treated with antibiotics, vasopressors were weaned off.  The patient did have melanotic stools (1/3/25, consistent with GI bleeding as the source of her acute blood loss anemia.  Gastroenterology was consulted.  Radiation oncology was also consulted.  Patient's condition medically improved (1/4/25) and she was transferred to the Internal Medicine Service.  A rapid response was initiated (1/5/25) due to hypoxia and hypotension.  After discussing the patient's poor prognosis with family goals of care were transition to comfort care.  The patient developed asystole (lead placement confirmed), pupils unresponsive, no carotid pulse palpated, and she was pronounced dead at 01:50 (1/6/25).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Intensive care, Melaena, Metastases to muscle, Metastases to soft tissue
Clinical narrative: HOSPITALS CRITICAL CARE Discharged as Deceased Summary  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO  Admission Date: 12/31/2024 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hemorrhagic shock [R57.8] Hypotension [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID [U07.1]  HOSPITAL COURSE: Patient is a 72 y.o. female w/ PMHx metastatic squamous cell carcinoma of the right upper lobe with T12 pathologic fracture status post kyphoplasty, atrial fibrillation, HFrEF (LVEF 40%) and chronic lower back pain who presented from local skilled nursing home 12/31/2024 9:08 PM due to nausea, vomiting, and generalized weakness found to be in shock. ICU consulted for medical admission. Workup in the ED showed COVID-19 infection, normocytic anemia, hemoglobin 6.3 down from 11.6 (12/7/24), acute kidney injury creatinine 2.4 up from 0.9, hyperkalemia (K 6.1), WBCs 20.4. CT abdomen and pelvis with new L1 end-plate and left iliac lytic lesions along with left oblique musculature soft tissue metastasis. CT angiogram with increasing size of the right lower lobe nodule since (10/24/24). The patient remained hypotensive despite 2 L normal saline, and 1 unit packed red blood cells.  Peripheral norepinephrine was started in the emergency department in the patient was transferred to the ICU for further management.  Patient was empirically treated with antibiotics, vasopressors were weaned off.  The patient did have melanotic stools (1/3/25, consistent with GI bleeding as the source of her acute blood loss anemia.  Gastroenterology was consulted.  Radiation oncology was also consulted.  Patient's condition medically improved (1/4/25) and she was transferred to the Internal Medicine Service.  A rapid response was initiated (1/5/25) due to hypoxia and hypotension.  After discussing the patient's poor prognosis with family goals of care were transition to comfort care.  The patient developed asystole (lead placement confirmed), pupils unresponsive, no carotid pulse palpated, and she was pronounced dead at 01:50 (1/6/25).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Normocytic anaemia, Pulmonary mass, Pulse absent, Pupil fixed
Clinical narrative: HOSPITALS CRITICAL CARE Discharged as Deceased Summary  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO  Admission Date: 12/31/2024 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hemorrhagic shock [R57.8] Hypotension [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID [U07.1]  HOSPITAL COURSE: Patient is a 72 y.o. female w/ PMHx metastatic squamous cell carcinoma of the right upper lobe with T12 pathologic fracture status post kyphoplasty, atrial fibrillation, HFrEF (LVEF 40%) and chronic lower back pain who presented from local skilled nursing home 12/31/2024 9:08 PM due to nausea, vomiting, and generalized weakness found to be in shock. ICU consulted for medical admission. Workup in the ED showed COVID-19 infection, normocytic anemia, hemoglobin 6.3 down from 11.6 (12/7/24), acute kidney injury creatinine 2.4 up from 0.9, hyperkalemia (K 6.1), WBCs 20.4. CT abdomen and pelvis with new L1 end-plate and left iliac lytic lesions along with left oblique musculature soft tissue metastasis. CT angiogram with increasing size of the right lower lobe nodule since (10/24/24). The patient remained hypotensive despite 2 L normal saline, and 1 unit packed red blood cells.  Peripheral norepinephrine was started in the emergency department in the patient was transferred to the ICU for further management.  Patient was empirically treated with antibiotics, vasopressors were weaned off.  The patient did have melanotic stools (1/3/25, consistent with GI bleeding as the source of her acute blood loss anemia.  Gastroenterology was consulted.  Radiation oncology was also consulted.  Patient's condition medically improved (1/4/25) and she was transferred to the Internal Medicine Service.  A rapid response was initiated (1/5/25) due to hypoxia and hypotension.  After discussing the patient's poor prognosis with family goals of care were transition to comfort care.  The patient developed asystole (lead placement confirmed), pupils unresponsive, no carotid pulse palpated, and she was pronounced dead at 01:50 (1/6/25).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell transfusion, Sepsis, Shock haemorrhagic, Vomiting, White blood cell count increased
Clinical narrative: HOSPITALS CRITICAL CARE Discharged as Deceased Summary  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO  Admission Date: 12/31/2024 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hemorrhagic shock [R57.8] Hypotension [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID [U07.1]  HOSPITAL COURSE: Patient is a 72 y.o. female w/ PMHx metastatic squamous cell carcinoma of the right upper lobe with T12 pathologic fracture status post kyphoplasty, atrial fibrillation, HFrEF (LVEF 40%) and chronic lower back pain who presented from local skilled nursing home 12/31/2024 9:08 PM due to nausea, vomiting, and generalized weakness found to be in shock. ICU consulted for medical admission. Workup in the ED showed COVID-19 infection, normocytic anemia, hemoglobin 6.3 down from 11.6 (12/7/24), acute kidney injury creatinine 2.4 up from 0.9, hyperkalemia (K 6.1), WBCs 20.4. CT abdomen and pelvis with new L1 end-plate and left iliac lytic lesions along with left oblique musculature soft tissue metastasis. CT angiogram with increasing size of the right lower lobe nodule since (10/24/24). The patient remained hypotensive despite 2 L normal saline, and 1 unit packed red blood cells.  Peripheral norepinephrine was started in the emergency department in the patient was transferred to the ICU for further management.  Patient was empirically treated with antibiotics, vasopressors were weaned off.  The patient did have melanotic stools (1/3/25, consistent with GI bleeding as the source of her acute blood loss anemia.  Gastroenterology was consulted.  Radiation oncology was also consulted.  Patient's condition medically improved (1/4/25) and she was transferred to the Internal Medicine Service.  A rapid response was initiated (1/5/25) due to hypoxia and hypotension.  After discussing the patient's poor prognosis with family goals of care were transition to comfort care.  The patient developed asystole (lead placement confirmed), pupils unresponsive, no carotid pulse palpated, and she was pronounced dead at 01:50 (1/6/25).
Age: 9.0
Sex: F
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: WE GAVE INCORRECTLY WRONG VACCINE TO A 9 YEARS OLD CHLID.
Age: 1.0
Sex: M
Vaccine: FLU3, HEPA, MMR, MMRV, PNC20
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive, Seizure
Clinical narrative: Patient received dose of Varivax and dose of Proquad on 12/18/24.  Patient was seen in ER on 12/27/24 for fever and seizure per parent. At the time of ER visit patient tested positive for Covid. Patient followed up with our office on 12/30/24. At the time of office visit on 12/30/24 patient vitals did not reflect fever at that time.
Age: 0.42
Sex: M
Vaccine: FLU3, HIBV
Symptoms: Expired product administered
Clinical narrative: Hib vaccine was expired on 12/31/2024 flu shot was not ordered and accidentally given.
Age: 7.0
Sex: M
Vaccine: DTAP
Symptoms: Wrong product administered
Clinical narrative: WE GAVE INCORRECTLY THE WRONG VACCINATION.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Biopsy lymph gland, Computerised tomogram, Head discomfort, Lymphadenopathy, Musculoskeletal discomfort
Clinical narrative: Received Fluad 65+ .5 ml IM on 10/06/24.  Had some neck and head discomfort after vaccination soon after.  About 2 weeks after vaccination noted swollen lymph node above left clavicle area.  Lymph node biopsy performed today as node did not go away.   Results pending. May or may not be related to vaccination but somewhat coincidental. This was the first time I had the high dose flu vaccine.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Scan with contrast, Ultrasound scan
Clinical narrative: Received Fluad 65+ .5 ml IM on 10/06/24.  Had some neck and head discomfort after vaccination soon after.  About 2 weeks after vaccination noted swollen lymph node above left clavicle area.  Lymph node biopsy performed today as node did not go away.   Results pending. May or may not be related to vaccination but somewhat coincidental. This was the first time I had the high dose flu vaccine.
Age: 26.0
Sex: M
Vaccine: HEPA
Symptoms: Dyskinesia, Flat affect, Muscle disorder, Muscle twitching, Musculoskeletal stiffness
Clinical narrative: The patient fainted and after we revived him by talking to him and making him sit straight in the chair, he started to sieze. The symptoms were classical motor symptoms of  blank stare, Jerking or twitching movements, Stiffening of the body, Loss of muscle control. We administered 1 dose 0.3mg of epinepherin auto injector, he became normal within a few seconds. We had called 911 and the medics were on site right away in a few few minutes. They evaluated him and asked him to take him to the hospital, which he refused. They stayed with him for about half an hour and he was feeling well enough to go home. He sat in his car for a while, we offered our help in any way he needed but he said he was fine. We reached out to him again this morning (1/9/2025) and he was feeling fine. I educated him about getting any vaccine in a medical facility and let his physician know about this episode.
Age: 26.0
Sex: M
Vaccine: HEPA
Symptoms: Seizure, Syncope
Clinical narrative: The patient fainted and after we revived him by talking to him and making him sit straight in the chair, he started to sieze. The symptoms were classical motor symptoms of  blank stare, Jerking or twitching movements, Stiffening of the body, Loss of muscle control. We administered 1 dose 0.3mg of epinepherin auto injector, he became normal within a few seconds. We had called 911 and the medics were on site right away in a few few minutes. They evaluated him and asked him to take him to the hospital, which he refused. They stayed with him for about half an hour and he was feeling well enough to go home. He sat in his car for a while, we offered our help in any way he needed but he said he was fine. We reached out to him again this morning (1/9/2025) and he was feeling fine. I educated him about getting any vaccine in a medical facility and let his physician know about this episode.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Exposure during pregnancy, Product use issue
Clinical narrative: MMR vaccine was administered to patient known to be pregnant. Patient was 23 weeks pregnant at time of administration. Patient and OBGYN provider notified.
Age: 0.33
Sex: F
Vaccine: DTAPIPV, HIBV, MENB, RV1
Symptoms: No adverse event, Wrong product administered
Clinical narrative: PT was due to receive their PCV 20 vaccine, instead of giving PCV 20 pt was administered Trumenva vaccine. PT has had no symptoms of adverse effects, spoke to pt mother who stated pt is doing fine